Viewing Study NCT00619502


Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-02-28 @ 10:37 PM
Study NCT ID: NCT00619502
Status: COMPLETED
Last Update Posted: 2016-05-13
First Post: 2008-02-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diphtheria View
None Polio View
None Pertussis View
None Hepatitis B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hepatitis B View
None Polio View
None Diphtheria View
None Pertussis View
None H.influenzae type b View